Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticleResearch

Family physician access to and wait times for cancer diagnostic investigations

Regional differences among 3 provinces

Andriana Barisic, Maxine Kish, Julie Gilbert, Nicole Mittmann, Rahim Moineddin, Jeffrey Sisler, Peter Vedsted and Eva Grunfeld
Canadian Family Physician October 2016, 62 (10) e599-e607;
Andriana Barisic
Senior Research Associate for the Ontario Renal Network of Cancer Care Ontario in Toronto, Ont, and was with the Department of Prevention and Cancer Control at the time of manuscript development.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andriana.barisic@renalnetwork.on.ca
Maxine Kish
Research Associate at Cancer Care Ontario and was a master’s student in the Department of Pharmacology and Toxicology at the University of Toronto.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Gilbert
Staff scientist and Manager of Research and Evaluation at Cancer Care Ontario and Adjunct Professor in the Institute for Health Policy, Management and Evaluation at the University of Toronto.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Mittmann
Chief Research Officer at Cancer Care Ontario.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahim Moineddin
Professor and a senior biostatistician in the Department of Family and Community Medicine at the University of Toronto.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Sisler
Chair of the College of Family Physicians of Canada’s Cancer Care Program of the Section of Communities of Practice in Family Medicine and Vice-Dean of the Office of Continuing Competency and Assessment in the Faculty of Health Sciences and Professor in the Department of Family Medicine at the University of Manitoba in Winnipeg.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Vedsted
Professor in the Research Unit for General Practice in the Department of Public Health at Aarhus University in Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Grunfeld
Giblon Professor and Vice-Chair of Research in the Department of Family and Community Medicine at the University of Toronto and Director of Knowledge Translation Research in the Health Services Research Program at the Ontario Institute for Cancer Research.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Objective To examine provincial and regional differences in FPs’ direct access to cancer diagnostic investigations and advice from other specialists regarding investigations and referrals, and to explore FPs’ perceptions about wait times for diagnostic investigations and receipt of results.

Design A cross-sectional, online survey.

Setting British Columbia, Manitoba, and Ontario.

Participants A sample of FPs from participating provinces.

Main outcome measures Direct FP access to various diagnostic investigations and advice from other specialists regarding investigations and referrals; FPs’ perceptions about wait times for diagnostic investigations ordered directly; and FPs’ perceptions about wait times for results.

Results A total of 1054 surveys were completed by FPs from British Columbia (n = 229), Manitoba (n = 228), and Ontario (n = 597). Distance from a cancer centre was not significantly associated with direct access to or wait times for diagnostic investigations for most of the investigations studied; however, provincial differences were observed. Family physicians in Manitoba and British Columbia were 30% to 45% less likely to report having direct access to endoscopy and some imaging investigations compared with FPs in Ontario. Family physicians in Manitoba and British Columbia were also at increased odds of waiting longer than 12 weeks for endoscopy investigations and longer than 4 weeks for imaging investigations compared with FPs in Ontario. Most FPs reported wait times of less than 2 weeks for imaging results; however, the proportion of FPs who waited longer than 2 weeks for colonoscopy results ranged from 15% in Ontario to 96% in British Columbia.

Conclusion Given the disparities observed among provinces, there is an opportunity for provinces to learn from one another to improve direct access to and shorten wait times for diagnostic investigations. This in turn has the potential to shorten the primary care interval for cancer diagnostic assessment.

Cancer outcomes differ substantially among Canadian provinces and by urban or rural status.1–5 There is evidence that poorer outcomes might be associated with a longer diagnostic time interval (time between onset of symptoms and diagnosis).6–10 The primary care interval (time between first presentation to primary care and the request for referral) represents a large segment of the diagnostic time interval, and thus it is reasonable to expect that primary care delays might influence outcomes.11 Further, a longer diagnostic interval might also lead to increased patient anxiety and dissatisfaction, and result in inefficiencies in the health care system. There is limited research examining this, especially in the Canadian context; thus the objectives of this study were to examine provincial and regional differences in factors that influence the primary care interval including direct FP access to cancer diagnostic investigations and advice from other specialists, and FPs’ perceptions about wait times for diagnostic investigations and receipt of results.

METHODS

The International Cancer Benchmarking Partnership is a collaboration of 13 jurisdictions: New South Wales and Victoria (Australia); British Columbia, Manitoba, Ontario, and Alberta (Canada); Denmark; Norway; Sweden; and England, Wales, Northern Ireland, and Scotland (United Kingdom). It comprises 5 modules, each examining a different hypothesis to explain observed international differences in cancer survival.1,12 This paper reports the Canadian results of module 3, which examined the role of primary care in cancer diagnosis. Each jurisdiction sought individual research ethics board approval (from the University of Toronto in Ontario; the University of Manitoba and CancerCare Manitoba; and the University of British Columbia). Additional information on the International Cancer Benchmarking Partnership has been published elsewhere.12

Study design and participants

This study used a cross-sectional, online survey of FPs who were invited to participate via postal mail or e-mail between June 11, 2012, and March 31, 2013. Lists of licensed, registered FPs were provided by the respective provincial bodies responsible for the regulation of family medicine in participating provinces. The recruitment strategies are outlined in Table 1. Participants were not eligible if they indicated on the initial eligibility screening question that they were not involved in direct clinical care or they were not an FP. Each jurisdiction aimed to recruit 200 FPs to meet the sample size requirement for the larger international study (which gave a 95% CI of 43% to 57% for an equally distributed response).

View this table:
  • View inline
  • View popup
Table 1.

Comparison of recruitment strategies

Survey content and development

The survey examined FPs’ demographic characteristics; FPs’ direct access to diagnostic investigations and advice from other specialists within 48 hours regarding cancer investigations and referrals; FPs’ perceived wait times for investigations; and practice organization factors. Details of survey development and validation have been previously reported.7,13

Statistical analyses

We used Embedded Image2 tests to examine provincial and regional differences in demographic characteristics, FPs’ direct access to diagnostic investigations and advice from other specialists, and FPs’ perceptions about wait times for diagnostic investigations ordered directly and wait times for the receipt of results. To evaluate regional differences within provinces, distance from a specialist cancer centre was defined using the question, “Do more than half of your patients live more than 40 km from the nearest centre with specialist cancer services?” Family physicians who answered yes were coded as distant; those who answered no were coded as close. To correct for multiple comparisons, false discovery rate P values were calculated and reported.14

Logistic regression was conducted to assess associations between FPs’ direct access to diagnostic investigations (yes or no) and ability to obtain advice from other specialists (measured on a 5-point Likert scale and collapsed into 2 response options: strongly agree or agree versus neutral, disagree, or strongly disagree), and the predictors of region and province. Multinomial logistic regression was conducted to examine associations between FPs’ perceptions about wait times for diagnostic investigations ordered directly and for receipt of results, and the predictors of region and province. An a priori decision was made to adjust all models for the country in which participants obtained their medical degrees and the ability to arrange faster access to investigations when there was high suspicion of cancer (access to and wait times for the conduction of investigations models) or systems used to ensure investigations are followed up (receipt of results models). Wait times were collapsed into 3 response categories post hoc, dependent on the distribution of responses (ie, to ensure that the response option categories were informative).

RESULTS

Demographic characteristics of the respondents are presented in Table 2. A total of 1054 surveys were used in the analyses: 229 from British Columbia, 228 from Manitoba, and 597 from Ontario, representing response rates of 5%, 46%, and 19%, respectively. The proportion of distant FPs varied across provinces from 30% in Ontario to 47% in Manitoba. Demographic characteristics of FPs were not significantly different between regions, with the exception of the country in which the medical degree was obtained (a higher percentage of distant FPs and FPs from Manitoba received their degrees outside of Canada). The percentage of FPs who reported that they could not arrange faster access to investigations in the context of high clinical suspicion ranged from 9% (Ontario) to 15% (Manitoba). In all regions, less than 10% of FPs reported having no system for or relying on their patients to ensure follow-up of investigation results.

View this table:
  • View inline
  • View popup
Table 2.

Demographic characteristics of participants, by province

Family physicians reported similar direct access to diagnostic investigations and advice from other specialists regardless of their distance from a cancer centre, with the exception of magnetic resonance imaging (MRI); 78% of distant FPs reported having direct access compared with 88% of close FPs (P < .001). Additionally, a greater percentage of distant FPs waited less than 2 weeks for computed tomography (CT) compared with close FPs (46% vs 29%, P < .001). Conversely, a greater percentage of close FPs reported waiting less than 2 weeks for ultrasound scans compared with distant FPs (56% vs 45%, P = .003). No significant differences in the wait times for results were observed.

Responses about direct access to diagnostic investigations and advice from other specialists and perceptions about wait times, by province, are outlined in Tables 3 to 5. Compared with FPs in Ontario, FPs in British Columbia were approximately 2.5 times more likely to report having access to advice from other specialists. With respect to direct access to endoscopy investigations, FPs in Manitoba and British Columbia were approximately 30% (British Columbia) and 45% (Manitoba) less likely to report having direct access to upper gastrointestinal endoscopy and colonoscopy. Family physicians in Manitoba were also 30% to 46% less likely to report having direct access to all imaging investigations (x-ray and ultrasound scans, CT, and MRI), and FPs in British Columbia were 27% less likely to report having direct access to MRI (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Direct FP access to advice from other specialists and diagnostic investigations, by province

View this table:
  • View inline
  • View popup
Table 4.

Family physicians’ perceived wait times for diagnostic imaging, by province

View this table:
  • View inline
  • View popup
Table 5.

Family physicians’ perceived wait times for results of diagnostic investigations, by province

Overall, FPs in Manitoba and British Columbia were at increased odds of waiting longer for diagnostic investigations to be conducted and results to be received compared with FPs in Ontario. Family physicians in Manitoba and British Columbia were 5 to 10 times more likely to wait longer than 12 weeks for endoscopy (Table 4). Notably, 71% of FPs in British Columbia reported waiting longer than 12 weeks for MRIs compared with 10% in Ontario (odds ratio of 34.71, 95% CI 18.66 to 64.57) (Table 4). Finally, in Manitoba, 61% of FPs waited longer than 4 weeks for ultrasound compared with only 7% in Ontario (odds ratio of 50.20, 95% CI 29.24 to 86.20).

DISCUSSION

A high proportion (84% to 96%) of all FPs reported having direct access to imaging, but access to endoscopy was low (16% to 17%). Although most FPs reported receiving the results of diagnostic investigations within 2 weeks (with the exception of colonoscopy), approximately a quarter of FPs reported waiting longer than 12 weeks for endoscopy investigations to be conducted, and waiting longer than 4 weeks for imaging investigations to be conducted, indicating that FPs self-reported having better access to imaging than to endoscopy. This might influence FP behaviour and the speed of diagnostic workup of patients. While it has been previously shown that access to diagnostic investigations was not associated with FP readiness to investigate or refer,7 access might influence which investigations to order. This might result in investigations that are less likely to definitively confirm cancer, thereby increasing patient anxiety and the diagnostic interval. Indeed, a randomized control study in Denmark found that patients of FPs with direct access to CT scans had shorter diagnostic intervals.15

This study did not find patterns in differences by distance from a centre with specialist cancer services; however, provincial differences were observed. A higher percentage of FPs in British Columbia reported having access to advice from other specialists compared with FPs in Ontario and Manitoba. This could be attributed to the Rapid Access to Consultative Expertise initiative in British Columbia, where FPs have access to real-time specialist advice via a telephone line. Conversely, FPs in British Columbia and Manitoba were at decreased odds of having direct access to upper gastrointestinal endoscopy and colonoscopy, and FPs in Manitoba were at decreased odds of having direct access to all imaging investigations compared with FPs in Ontario.

Family physicians in British Columbia and Manitoba were at increased odds of waiting longer for diagnostic investigations and results compared with FPs in Ontario. This is consistent with previous research examining wait times for medical imaging. The Canadian Institute for Health Information has reported that the 50th percentile for MRI and CT wait times was longer in Manitoba compared with Ontario (99 vs 36 days for MRI and 18 vs 7 days for CT); British Columbia wait times were not reported.16

Limitations

This study has several limitations. First, the question, “Do more than half of your patients live more than 40 km from the nearest centre with specialist cancer services?” was used as a proxy for examining regional differences, as it was not possible to geographically locate FP practice address in all provinces. Consequently, it is possible that misclassification occurred, which would bias the results toward the null hypothesis. However, geocoding was conducted in Ontario according to the population centre definition from the 2011 Canadian census, and the agreement between urban or rural status and distance from the nearest centre with specialist cancer services was 81.3% (κ = 0.56, 95% CI 0.49 to 0.64, P < .001). Second, the regression analyses suffered from low power. Nevertheless, the magnitude of the odds ratios and the statistical significance indicate that the associations observed are clinically meaningful and real. Third, the results of this study are self-reported and are thus subject to recall bias. Further, because the data are self-reported, FP access to investigations and wait times are based on FP perception. Fourth, the external validity of this study is compromised owing to low response rates. Moreover, our recruitment methodology was dependent on jurisdictional feasibility, and thus response rates (and likely the study populations) varied substantially by province. Fifth, external validity was also compromised because rural FPs were oversampled in Manitoba and Ontario. Although greater regional representation can be interpreted as a study strength, it is conceivable that access and wait times might differ by urban or rural status.

Conclusion

Despite these limitations, this study adds to the literature by examining regional and provincial differences in Canada with respect to factors that influence the primary care and diagnostic intervals for cancer. Statistically significant provincial differences in wait times and FPs’ direct access to diagnostic investigations were observed. Although urban and rural differences could not be directly examined, using distance from a cancer centre as a proxy, the provincial differences observed do not appear to be attributed to other regional differences. Consequently, this study demonstrates that there is considerable opportunity for provinces to learn from one another’s strengths and weaknesses. Although it is unknown whether the provincial differences observed influence outcomes, we do know that the diagnostic interval has been shown to influence patient outcomes. Given that the primary care interval is a large segment of the diagnostic interval, not only does a longer primary care interval potentially result in poorer outcomes, affecting survival and stage progression, it also likely increases patient anxiety and dissatisfaction, and might lead to inefficiencies in the health care system. Thus it is important to identify factors within primary care that might decrease the time to cancer diagnosis.

Notes

EDITOR’S KEY POINTS

  • Previous research has demonstrated that the diagnostic interval (the time between onset of symptoms and diagnosis) influences cancer outcomes. Because the primary care interval represents a large segment of the diagnostic interval, this study aimed to examine primary care factors that might influence the diagnostic interval and in turn affect cancer outcomes.

  • Considerable provincial differences were observed. A higher percentage of FPs in British Columbia reported having access to advice from other specialists within 48 hours compared with FPs in Ontario and Manitoba, and FPs in British Columbia and Manitoba were at increased odds of waiting longer for diagnostic investigations and results compared with FPs in Ontario.

  • Family physicians self-reported having better access to imaging than to endoscopy. Although the survey did not examine FP behaviour, this differential access has the potential to influence which investigations FPs order and consequently the speed of diagnostic workup of patients. It could result in investigations that are less likely to definitively confirm cancer, thereby increasing patient anxiety and the diagnostic interval.

POINTS DE REPÈRE DU RÉDACTEUR

  • Des études antérieures ont montré que l’intervalle diagnostique (la période entre le début des symptômes et le diagnostic) influence les issues d’un cancer. Comme l’intervalle pour les premiers soins représente une portion considérable de l’intervalle diagnostique, cette étude voulait déterminer si certains facteurs liés aux soins primaires pouvaient influencer l’intervalle diagnostique et ainsi affecter les issues d’un cancer.

  • D’importantes différences ont été observées entre les provinces. Par rapport aux MF du Manitoba et de l’Ontario, un plus fort pourcentage de ceux de la Colombie-Britannique ont déclaré avoir accès à des conseils d’autres spécialistes dans les 48 heures; par ailleurs, ceux de Colombie Britannique et du Manitoba étaient plus susceptibles d’attendre plus longtemps que ceux de l’Ontario pour les examens diagnostiques et pour les résultats.

  • Les médecins de famille ont déclaré avoir un meilleur accès à l’imagerie qu’à l’endoscopie. Même si l’enquête ne vérifiait pas le comportement des MF, une telle différence pourrait influencer le choix des examens demandés et donc, la rapidité avec laquelle le diagnostic est établi. Le médecin pourrait donc demander des examens qui sont moins susceptibles de confirmer la présence d’un cancer, augmentant ainsi l’anxiété du patient et l’intervalle diagnostique.

Footnotes

  • This article has been peer reviewed.

  • Cet article a fait l’objet d’une révision par des pairs.

  • Contributors

    All authors contributed to the concept and design of the study; data gathering, analysis, and interpretation; and preparing the manuscript for submission.

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Coleman MP,
    2. Forman D,
    3. Bryant H,
    4. Butler J,
    5. Rachet B,
    6. Maringe C,
    7. et al
    . Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377(9760):127-38. Epub 2010 Dec 21.
    OpenUrlCrossRefPubMed
  2. 2.
    1. Hallet J,
    2. Law CH,
    3. Karanicolas PJ,
    4. Saskin R,
    5. Liu N,
    6. Singh S
    . Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: a population-based analysis of 6271 cases. Cancer 2015;121(13):2214-21. Epub 2015 Mar 30.
    OpenUrlCrossRefPubMed
  3. 3.
    1. Leung J,
    2. McKenzie S,
    3. Martin J,
    4. McLaughlin D
    . Effect of rurality on screening for breast cancer: a systematic review and meta-analysis comparing mammography. Rural Remote Health 2014;14(2):2730. Epub 2014 Jun 23.
    OpenUrlPubMed
  4. 4.
    1. Obertova Z,
    2. Brown C,
    3. Holmes M,
    4. Lawrenson R
    . Prostate cancer incidence and mortality in rural men—a systematic review of the literature. Rural Remote Health 2012;12(2):2039. Epub 2012 May 21.
    OpenUrlPubMed
  5. 5.↵
    1. Torabi M,
    2. Green C,
    3. Nugent Z,
    4. Mahmud S,
    5. Demers A,
    6. Griffith J,
    7. et al
    . Geographical variation and factors associated with colorectal cancer mortality in a universal health care system. Can J Gastroenterol Hepatol 2014;28(4):191-7.
    OpenUrlPubMed
  6. 6.↵
    1. Torring ML,
    2. Frydenberg M,
    3. Hansen RP,
    4. Olesen F,
    5. Vedsted P
    . Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 2013;49(9):2187-98. Epub 2013 Feb 27.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Rose PW,
    2. Rubin G,
    3. Perera-Salazar R,
    4. Almberg SS,
    5. Barisic A,
    6. Dawes M,
    7. et al
    . Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open 2015;5(5):e007212.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Richards MA,
    2. Westcombe AM,
    3. Love SB,
    4. Littlejohns P,
    5. Ramirez AJ
    . Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353(9159):1119-26.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Neal RD,
    2. Tharmanathan P,
    3. France B,
    4. Din NU,
    5. Cotton S,
    6. Fallon-Ferguson J,
    7. et al
    . Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015;112(Suppl 1):S92-107.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Neal RD
    . Do diagnostic delays in cancer matter? Br J Cancer 2009;101(Suppl 2):S9-12.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Weller D,
    2. Vedsted P,
    3. Rubin G,
    4. Walter FM,
    5. Emery J,
    6. Scott S,
    7. et al
    . The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012;106(7):1262-7. Epub 2012 Mar 13.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Butler J,
    2. Foot C,
    3. Bomb M,
    4. Hiom S,
    5. Coleman M,
    6. Bryant H,
    7. et al
    . The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy 2013;112(1–2):148-55. Epub 2013 May 18.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Rose PW,
    2. Hamilton W,
    3. Aldersey K,
    4. Barisic A,
    5. Dawes M,
    6. Foot C,
    7. et al
    . Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions. BMC Fam Pract 2014;15:122.
    OpenUrlPubMed
  14. 14.↵
    1. Storey JD,
    2. Taylor JE,
    3. Siegmund D
    . Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J R Stat Soc Series B Stat Methodol 2004;66(1):187-205.
    OpenUrlCrossRef
  15. 15.↵
    1. Guldbrandt LM,
    2. Fenger-Gron M,
    3. Rasmussen TR,
    4. Rasmussen F,
    5. Meldgaard P,
    6. Vedsted P
    . The effect of direct access to CT scan in early lung cancer detection: an unblinded, cluster-randomised trial. BMC Cancer 2015;15:934.
    OpenUrlPubMed
  16. 16.↵
    1. Canadian Institute for Health Information.
    Wait times for priority procedures in Canada, 2016. Ottawa, ON: Canadian Institute for Health Information; 2016. Available from: https://secure.cihi.ca/free_products/wait_time_report2016_en.pdf. Accessed 2016 Apr 14.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 62 (10)
Canadian Family Physician
Vol. 62, Issue 10
1 Oct 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Family physician access to and wait times for cancer diagnostic investigations
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Family physician access to and wait times for cancer diagnostic investigations
Andriana Barisic, Maxine Kish, Julie Gilbert, Nicole Mittmann, Rahim Moineddin, Jeffrey Sisler, Peter Vedsted, Eva Grunfeld
Canadian Family Physician Oct 2016, 62 (10) e599-e607;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Family physician access to and wait times for cancer diagnostic investigations
Andriana Barisic, Maxine Kish, Julie Gilbert, Nicole Mittmann, Rahim Moineddin, Jeffrey Sisler, Peter Vedsted, Eva Grunfeld
Canadian Family Physician Oct 2016, 62 (10) e599-e607;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Ca prend une equipe: CanIMPACT : Equipe canadienne pour ameliorer les soins communautaires en cancerologie tout au long du continuum
  • It takes a team: CanIMPACT: Canadian Team to Improve Community-Based Cancer Care along the Continuum
  • Google Scholar

More in this TOC Section

  • Systematic assessment of opioid advertisements in general medical journals
  • Timely access to primary care in New Brunswick
  • Older persons living with dementia and their use of acute care services over 2 years in Alberta
Show more Research

Similar Articles

Subjects

  • Collection française
    • Résumés de recherche

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire